Sichenzia Ross Ference represented Aegis Capital Corp. as sole book running manager in the offering.BiondVax Pharmaceuticals executed the $8 Million underwritten public offering. The offering consisted of…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
